Investor Centre

Investor Fact Sheet

Open 0.15
High 0.15
Low 0.15
Volume 119,559
( 0.0%
As at 3:58PM 18/12/2017

Investor Fact Sheet

Acrux is a dynamic Australian drug delivery business developing and commercialising a range of patient-preferred pharmaceutical products for global markets, using innovative, patented technology to administer drugs to humans and animals.

Acrux Limited is a Pooled Development Fund. Shareholders will be entitled to concessionary tax treatment in Australia for income and capital gains derived in connection with their shareholding.  Non–residents will not be subject to withholding tax on dividends paid.  A shareholder or potential Shareholder should obtain their own tax advice rather than relying on this summary.

Learn more about Acrux Learn more about our history

Security Information

Share Price 

Acrux is listed on the Australian Securities Exchange (ASX code: ACR).

View Share Price Information View Announcements & Reports

Board of Directors

Ross Dobinson — Non-Executive Chairman
Geoff Brooke — Non-Executive Director
Tim Oldham — Non-Executive Director

Michael Kotsanis — CEO & Managing Director
Simon Green — Non-Executive Director

Tim Oldham — Chair, Human Capital Committee

Geoff Brooke — Chair, Audit and Risk Committee

Tim Bateman — CFO & Company Secretary


103-113 Stanley Street West Melbourne VIC 3003 Australia

Share Registry

Link Market Services
Level 1, 333 Collins Street
Locked Bag A14, Sydney South, NSW 1235

Toll-free: 1300 554 474 (Australia only)
International: +61 1300 554 474
Facsimile: (02) 9287 0303
Facsimile: (02) 9287 0309 (for proxy voting)

Web: in new window


Pitcher Partners
Level 19, 15 William St.
Melbourne VIC 3000

Telephone: +61 3 8610 5000
Facsimile: +61 3 8610 5999